Cambridge Investment Research Advisors Inc. raised its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 99,748 shares of the pharmacy operator’s stock after buying an additional 1,409 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $7,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Westside Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the period. IHT Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares during the period. Bristlecone Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $135,000. Finally, Private Vista LLC lifted its position in shares of Walgreens Boots Alliance by 6,403.7% in the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares during the period. 61.18% of the stock is owned by institutional investors.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $72.86 on Thursday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. The company has a market cap of $72,008.77, a P/E ratio of 19.28, a P/E/G ratio of 1.30 and a beta of 1.22. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.07 EPS. analysts forecast that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.20%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.

In related news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.

Several brokerages have recently weighed in on WBA. Needham & Company LLC lowered their price target on shares of Walgreens Boots Alliance to $86.00 and set a “buy” rating for the company in a research report on Wednesday, November 22nd. Jefferies Group set a $93.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Sunday, October 29th. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $86.60.

ILLEGAL ACTIVITY WARNING: “Cambridge Investment Research Advisors Inc. Grows Holdings in Walgreens Boots Alliance Inc (WBA)” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://theolympiareport.com/2017/12/28/cambridge-investment-research-advisors-inc-grows-holdings-in-walgreens-boots-alliance-inc-wba-2.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.